UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063655
Receipt number R000072705
Scientific Title Effects of 8-week intake of cocoa flavanol-containing food on skin condition
Date of disclosure of the study information 2026/11/17
Last modified on 2026/11/16 21:14:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of 8-week intake of cocoa flavanol-containing food on skin condition

Acronym

Effects of 8-week intake of cocoa flavanol-containing food on skin condition

Scientific Title

Effects of 8-week intake of cocoa flavanol-containing food on skin condition

Scientific Title:Acronym

Effects of 8-week intake of cocoa flavanol-containing food on skin condition

Region

Japan


Condition

Condition

Healthy Japanese

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of the intake of cocoa flavanol-containing food on skin condition (stratum corneum hydration, trans epidermal water loss, wrinkles, pigmentation, etc.).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stratum corneum hydration evaluated at baseline, 4 weeks, and 8 weeks

Key secondary outcomes

1. Trans epidermal water loss (TEWL) evaluated at baseline, 4 weeks, and 8 weeks
2. Wrinkles in the crow's feet area evaluated by skin replica analysis at baseline, 4 weeks, and 8 weeks
3. VISIA skin image analysis at baseline, 4 weeks, and 8 weeks
4. Incidence and severity of adverse events throughout the 8-week intervention period


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of cocoa flavanol-containing food (chocolate) once daily for 8 consecutive weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

65 years-old >=

Gender

Female

Key inclusion criteria

1. Healthy Japanese females aged 30 to 65 years at the time of obtaining informed consent.
2. Individuals who are aware of skin dryness, wrinkles, or dullness (pigmentation), or who wish to improve these conditions.
3. Individuals who have received a sufficient explanation regarding study participation, fully understand the details, and voluntarily provide written informed consent.

Key exclusion criteria

1.Individuals with a history of atopic dermatitis, or who are currently undergoing treatment for it.
2.Individuals with a history of, or currently receiving treatment for (including continuous medication use), serious diseases (such as cardiovascular, hepatic, renal, or gastrointestinal diseases) or lifestyle-related diseases (such as hypertension, diabetes, or dyslipidemia).
3.Individuals with skin disorders on the test site (face) that may interfere with the evaluation of study results (e.g., eczema, severe sunburn, severe acne).
4.Individuals with a history of hypersensitivity, allergy, or severe adverse reactions to chocolate or ingredients of the test product (milk, soy, wheat, egg, and cashew nut).
5.Individuals who routinely use or ingest medicines or dietary supplements aimed at improving skin conditions, and who cannot discontinue them during the study period.
6.Females who are pregnant, suspected of being pregnant, or lactating.
7.Individuals who have undergone aesthetic medical treatments on the face (e.g., laser therapy, light therapy, chemical peels, injectable treatments) within 3 months prior to the eligibility assessment, or who plan to undergo such treatments during the study period.
8.Individuals who have participated in other clinical trials (interventional studies) within 3 months prior to the eligibility assessment, or who plan to participate in other trials during this study period.
9.Other individuals deemed ineligible for participation in this study by the principal investigator or study director.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Kiyohide
Middle name
Last name Ishii

Organization

Ishii Dermatology Clinic

Division name

Director

Zip code

372-0812

Address

1585-1, Tsunatorimachi, Isesaki-shi, Gunma

TEL

0270-40-5566

Email

shoji.obuchi@oms-laboratory.co.jp


Public contact

Name of contact person

1st name Shoji
Middle name
Last name Obuchi

Organization

OMS Medical Laboratory Co., LTD.

Division name

Safety Testing Department

Zip code

377-0422

Address

68-4 Aoyama, Nakanojo-machi, Agatsuma-gun, Gunma

TEL

0279-26-9102

Homepage URL


Email

shoji.obuchi@oms-laboratory.co.jp


Sponsor or person

Institute

PlasMEDi Inc.

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Kan-etsu Chuo Hospital

Address

71 Kitahara-machi, Takasaki-shi, Gunma 370-3513, Japan

Tel

027-373-5115

Email

info@kan-etsu-hospital.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 09 Day

Date of IRB


Anticipated trial start date

2026 Year 11 Month 18 Day

Last follow-up date

2027 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 16 Day

Last modified on

2026 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072705